CoChat

Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial

Open access

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index; 11 of the 43 sources its claims cite were checked for support.

Abstract

BACKGROUND: Individuals with a history of recurrent depression have a high risk of repeated depressive relapse or recurrence. Maintenance antidepressants for at least 2 years is the current recommended treatment, but many individuals are interested in alternatives to medication. Mindfulness-based cognitive therapy (MBCT) has been shown to reduce risk of relapse or recurrence compared with usual care, but has not yet been compared with maintenance antidepressant treatment in a definitive trial. We aimed to see whether MBCT with support to taper or discontinue antidepressant treatment (MBCT-TS) was superior to maintenance antidepressants for prevention of depressive relapse or recurrence over 24 months. METHODS: In this single-blind, parallel, group randomised controlled trial (PREVENT), we recruited adult patients with three or more previous major depressive episodes and on a therapeutic dose of maintenance antidepressants, from primary care general practices in urban and rural settings in the UK. Participants were randomly assigned to either MBCT-TS or maintenance antidepressants (in a 1:1 ratio) with a computer-generated random number sequence with stratification by centre and symptomatic status. Participants were aware of treatment allocation and research assessors were masked to treatment allocation. The primary outcome was time to relapse or recurrence of depression, with patients followed up at five separate intervals during the 24-month study period. The primary analysis was based on the principle of intention to treat. The trial is registered with Current Controlled Trials, ISRCTN26666654. FINDINGS: Between March 23, 2010, and Oct 21, 2011, we assessed 2188 participants for eligibility and recruited 424 patients from 95 general practices. 212 patients were randomly assigned to MBCT-TS and 212 to maintenance antidepressants. The time to relapse or recurrence of depression did not differ between MBCT-TS and maintenance antidepressants over 24 months (hazard ratio 0·89, 95% CI 0·67-1·18; p=0·43), nor did the number of serious adverse events. Five adverse events were reported, including two deaths, in each of the MBCT-TS and maintenance antidepressants groups. No adverse events were attributable to the interventions or the trial. INTERPRETATION: We found no evidence that MBCT-TS is superior to maintenance antidepressant treatment for the prevention of depressive relapse in individuals at risk for depressive relapse or recurrence. Both treatments were associated with enduring positive outcomes in terms of relapse or recurrence, residual depressive symptoms, and quality of life. FUNDING: National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme, and NIHR Collaboration for Leadership in Applied Health Research and Care South West Peninsula.

Overview

CoChat Summary

TL;DR

In adults with recurrent depression and at least three prior major depressive episodes, mindfulness-based cognitive therapy with support to taper/discontinue antidepressants (MBCT-TS) was not superior to maintenance antidepressants for preventing depressive relapse or recurrence over 24 months. Both treatments were associated with enduring positive outcomes, and MBCT-TS was not more cost-effective than maintenance antidepressants.

Key findings

  • Primary outcome: no difference in time to relapse/recurrence over 24 months (HR 0.89, 95% CI 0.67–1.18; p=0.43); relapse occurred in 94/212 (44%) MBCT-TS participants vs 100/212 (47%) maintenance antidepressant participants.
  • Secondary outcomes showed no evidence of superiority of MBCT-TS over maintenance antidepressants; no secondary outcome treatment effect exceeded a standardised mean difference of 0.4.
  • Cost-effectiveness: MBCT-TS attendance cost £112 per participant; total health and social care cost did not differ significantly (mean difference £124, 95% CI −749.98 to 972.57; p=0.80). In QALYs, MBCT-TS was dominated by maintenance antidepressants, and the probability of MBCT-TS being more cost-effective did not rise above 52%.
  • Exploratory subgroup: a significant interaction with reported childhood abuse was noted; MBCT-TS reduced relapse/recurrence in the high-abuse subgroup (49/105 [47%] vs 65/111 [59%]) but showed slightly higher risk in the low-abuse subgroup (44/105 [42%] vs 35/101 [35%]).
  • Serious adverse events: ten reported, four fatal, evenly split between groups (three non-fatal and two fatal in each group); none attributed to the interventions or trial.

Methods

  • Multicentre, pragmatic, single-blind, parallel-group randomised controlled trial (PREVENT) in UK primary care; 424 adults with recurrent major depressive disorder in full or partial remission, ≥3 previous major depressive episodes, and on a therapeutic dose of maintenance antidepressants were recruited from 95 general practices and randomised 1:1 to MBCT-TS or maintenance antidepressants.
  • Primary outcome was time to relapse or recurrence of depression over 24 months, assessed retrospectively with the SCID depression module; primary analysis was intention-to-treat using Cox regression adjusted for stratification variables.
  • Secondary outcomes included depression-free days, residual depressive symptoms, psychiatric/medical comorbidity, quality of life, and cost-effectiveness; economic analysis used health and social care and societal perspectives, QALYs from EQ-5D, and cost-effectiveness acceptability curves.

Limitations

  • The paper states the sample was at high risk, currently taking antidepressants, and open both to a group psychosocial treatment and to discontinuing or continuing medication, so findings are generalisable only to individuals in equipoise about preventive treatment; recruitment was by primary care database search and invitation rather than GP discussion of options.
  • The paper states there was no usual care or attention control group, so effects of MBCT cannot be inferred to be specific to MBCT; the pragmatic design meant a subgroup in both groups did not comply with the invitation to discontinue antidepressants, so antidepressant medication was not fully controlled.
  • The text also makes evident that assessor masking fidelity was only moderate (assessors correctly guessed allocation for 56% of assessments), the adherence-based secondary analyses were non-randomised and prone to selection bias and confounding, and there was a protocol discrepancy: WHOQOL was not listed as a secondary outcome in the published protocol or ISRCTN register.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(14)62222-4

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Image 1
CC-BY · From the PDF
Figure 2 Survival curves (of not relapse or recurrence) over a 24-month follow-up period for the intention-to-treat population
Figure 2 Survival curves (of not relapse or recurrence) over a 24-month follow-up period for the intention-to-treat populationCC-BY · From the PDF

Verification

Claims the paper makes

10 Valid · 0 Not valid · 20 Not checked · 69 Own results and interpretations

31 more claims

Create a free account to see all 99 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 43
  • It may state two separate claims as one. 30

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

30 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 46 references

Research works printed but not linked: 1

  1. Williams, 1998, A structured clinical interview guide for the Hamilton Depression Rating Scale, Arch Gen Psychiatry, 45, 742, 10.1001/archpsyc.1988.01800320058007 · DOI

Cited by

See all 527

Metadata

Authors
Kuyken, W., Hayes, R., Barrett, B., Byng, R., Dalgleish, T., Kessler, D., Lewis, G., Watkins, E., Brejcha, C., Cardy, J., Causley, A., Cowderoy, S., Evans, A., Gradinger, F., Kaur, S., Lanham, P., Morant, N., Richards, J., Shah, P., Sutton, H., Vicary, R., Weaver, A., Wilks, J., Williams, M., Taylor, R. S., & Byford, S.
Affiliations
  • University of Exeter (GB)
  • King's College London (GB)
  • Peninsula College of Medicine and Dentistry (GB)
  • MRC Cognition and Brain Sciences Unit (GB)
  • University of Bristol (GB)
  • University College London (GB)
  • University of Cambridge (GB)
Corresponding author
Kuyken, Willem
Venue
The Lancet
Publisher
Elsevier BV
Published
2015-07
Volume
386
Issue
9988
Pages
63-73
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2163837537
Cited by
527
References
45
Citations by year
2026: 29 · 2025: 36 · 2024: 34 · 2023: 47 · 2022: 37 · 2021: 43 · 2020: 62 · 2019: 52 · 2018: 54 · 2017: 50 · 2016: 58 · 2015: 24
FWCI
76.87
Type
journal article
Language
en
Open access
Licence
Locations
  • The Lancet (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Figshare (submittedVersion)
  • Research Portal (King's College London) (submittedVersion, cc-by)
  • Open Research Exeter (University of Exeter) (submittedVersion, cc-by)
  • PEARL (University of Plymouth) (submittedVersion)
  • Bristol Research (University of Bristol) (submittedVersion, cc-by)
Funders
National Institute for Health Research Health Technology Assessment (NIHR HTA) programme (project number: 08/56/01)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
mindfulness-based cognitive therapy, relapse prevention, depression recurrence, recurrent depression, antidepressant tapering, antidepressant discontinuation, cost-effectiveness, primary care, serious adverse events
MeSH terms
Adult, Aged, Antidepressive Agents, Combined Modality Therapy, Major Depressive Disorder, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Quality of Life, Recurrence, Socioeconomic Factors, Cognitive Behavioral Therapy, Single-Blind Method, Treatment Outcome, Young Adult, Mindfulness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(14)62222-4
The paper
Kuyken, W., Hayes, R., Barrett, B., Byng, R., Dalgleish, T., Kessler, D., Lewis, G., Watkins, E., Brejcha, C., Cardy, J., Causley, A., Cowderoy, S., Evans, A., Gradinger, F., Kaur, S., Lanham, P., Morant, N., Richards, J., Shah, P., . . . Byford, S. (2015). Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(14)62222-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.